AVAILABLE MEDICINE FOR Ticagrelor
There are no products to list.
Introduction to Ticagrelor
Ticagrelor is an antiplatelet medication used to reduce the risk of stroke, heart attack, and other heart-related events in people with acute coronary syndrome.
How it Works:
Ticagrelor inhibits the P2Y12 receptor on platelets, preventing them from clumping together and forming clots.
Uses:
Prevention of thrombotic events in patients with acute coronary syndrome.
Side Effects:
- Bleeding
- shortness of breath.
FDA Approval:
Ticagrelor is approved by the FDA in 2011 under the brand name Brilinta.
